The following tables present the Company’s revenues by Segment and End Customer Geography (in millions):


	Three Months Ended June 30,						Six Months Ended June 30,
	2023			2022			2023			2022
Revenue by Segment:
BSI BioSpin	$	162.0		$	159.8		$	342.3		$	317.6
BSI CALID		227.2			190.3			463.9			393.5
BSI NANO		225.1			182.2			434.7			360.7
BEST		72.7			59.2			134.9			118.9
Eliminations (a)		(5.1	)		(3.1	)		(8.6	)		(7.3	)
Total revenue	$	681.9		$	588.4		$	1,367.2		$	1,183.4

(a)

Represents corporate costs and eliminations not allocated to the reportable segments.


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Revenue by End Customer Geography:
United States	$	179.3	$	171.5	$	354.4	$	326.5
Germany		61.5		67.3		124.1		125.8
Rest of Europe		161.2		130.3		321.0		273.7
China		116.5		93.1		224.1		179.4
Rest of Asia Pacific		106.8		83.4		239.4		186.0
Other		56.6		42.8		104.2		92.0
Total revenue	$	681.9	$	588.4	$	1,367.2	$	1,183.4

Revenue for the Company recognized at a point in time versus over time is as follows (in millions):


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Revenue recognized at a point in time	$	586.7	$	509.2	$	1,185.4	$	1,023.2
Revenue recognized over time		95.2		79.2		181.8		160.2
Total revenue	$	681.9	$	588.4	$	1,367.2	$	1,183.4

Remaining performance obligations represent the aggregate transaction price allocated to a promise to transfer a good or service that is fully or partially unsatisfied at the end of the period. As of June 30, 2023, remaining performance obligations were approximately $2,339.4 million.

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, note receivables and unbilled receivables (contract assets) and deferred revenue, customer deposits and billings in excess of revenue recognized (contract liabilities) on the Company’s unaudited condensed consolidated balance sheets.

Contract assets—Most of the Company’s long-term contracts are billed as work progresses in accordance with the contract terms and conditions, either at periodic intervals or upon achievement of certain milestones. Billing often occurs subsequent to revenue recognition, resulting in contract assets. Contract assets are generally classified as other current assets in the unaudited condensed consolidated balance sheets. The balance of contract assets as of June 30, 2023 and December 31, 2022 was $76.4 million and $61.3 million, respectively.

Contract liabilities—The Company often receives cash payments from customers in advance of the Company’s performance, resulting in contract liabilities. These contract liabilities are classified as either current or long-term in the unaudited condensed consolidated balance sheets based on the timing of when revenue recognition is expected. As of June 30, 2023 and December 31, 2022, the contract liabilities were $498.3 million and $471.7 million, respectively. The increase in the contract liability balance during the six months ended June 30, 2023 is primarily the result of new cash payments received, which was offset in part by satisfying performance obligations. Approximately $242.6 million of the contract liability balance on December 31, 2022 was recognized as revenue during the six months ended June 30, 2023.